Researchers have reviewed data on the incidence of autoimmune diseases in the post-acute coronavirus disease 2019 (COVID-19) period.

At six months of follow-up, autoimmune disease incidence was significantly greater in SARS-CoV-2-infected individuals, including systemic lupus erythematosus.